| scholarly article | Q13442814 |
| P50 | author | Jesse J. Kwiek | Q40470706 |
| Timothy A J Haystead | Q63176935 | ||
| P2093 | author name string | Patrick Fadden | |
| Michael Foley | |||
| Rupa Ray | |||
| Paul R Graves | |||
| Andrew M Coley | |||
| Klaas Hardeman | |||
| P2860 | cites work | Initial sequencing and analysis of the human genome | Q21045365 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1364-1372 | |
| P577 | publication date | 2002-12-01 | |
| P1433 | published in | Molecular Pharmacology | Q1943386 |
| P1476 | title | Discovery of novel targets of quinoline drugs in the human purine binding proteome | |
| P478 | volume | 62 |
| Q42030068 | 4-[(7-Fluoro-quinazolin-4-yl)-oxy]aniline |
| Q42149303 | A highly selective Hsp90 affinity chromatography resin with a cleavable linker |
| Q27678799 | A selective inhibitor reveals PI3Kγ dependence of T(H)17 cell differentiation |
| Q41911805 | ALDH1A1 and HLTF modulate the activity of lysosomal autophagy inhibitors in cancer cells |
| Q38561919 | Affinity purification in target identification: the specificity challenge |
| Q34076679 | Aldehyde dehydrogenase 3B1 (ALDH3B1): immunohistochemical tissue distribution and cellular-specific localization in normal and cancerous human tissues |
| Q46765640 | An unbiased evaluation of CK2 inhibitors by chemoproteomics: characterization of inhibitor effects on CK2 and identification of novel inhibitor targets |
| Q90748763 | Antimalarial Properties of Dunnione Derivatives as NQO2 Substrates |
| Q38908654 | Antimalarial activity of kinase inhibitor, nilotinib, in vitro and in vivo |
| Q35238319 | Antiparasitic chemotherapy: from genomes to mechanisms |
| Q50688423 | Application of isothermal titration calorimetry and column chromatography for identification of biomolecular targets. |
| Q30310873 | Can a proteomics strategy be used to identify the anti-malarial activity of chloroquine? |
| Q41927731 | Cellular fatty acid synthase is required for late stages of HIV-1 replication. |
| Q37234005 | Chemical and pathway proteomics: powerful tools for oncology drug discovery and personalized health care. |
| Q34342905 | Chemistry-based functional proteomics for drug target deconvolution |
| Q34331796 | Chloroquine binding reveals flavin redox switch function of quinone reductase 2. |
| Q28280502 | Crystal structure of quinone reductase 2 in complex with resveratrol |
| Q27676483 | Design, Synthesis, and Biological Evaluation of Potent Quinoline and Pyrroloquinoline Ammosamide Analogues as Inhibitors of Quinone Reductase 2 |
| Q46402017 | Evidence for NQO1 and NQO2 catalyzed reduction of ortho- and para-quinone methides |
| Q24683659 | Expression and initial characterization of human ALDH3B1 |
| Q48098001 | Expression of Quinone Reductase-2 in the Cortex Is a Muscarinic Acetylcholine Receptor-Dependent Memory Consolidation Constraint. |
| Q37760940 | Flavin-containing reductase: new perspective on the detoxification of nitrobenzodiazepine. |
| Q47362668 | Fluorescent-Linked Enzyme Chemoproteomic Strategy (FLECS) for Identifying HSP70 Inhibitors. |
| Q33209914 | Genome-wide characterisation of the binding repertoire of small molecule drugs |
| Q35785231 | Genomics and proteomics tools for compound mode-of-action studies in drug discovery |
| Q38265824 | Global discovery of protein kinases and other nucleotide-binding proteins by mass spectrometry |
| Q35875193 | Harvesting the genome's bounty: integrative genomics |
| Q37087345 | Identification of 4-aminoquinoline core for the design of new cholinesterase inhibitors |
| Q39515397 | Indolequinone inhibitors of NRH:quinone oxidoreductase 2. Characterization of the mechanism of inhibition in both cell-free and cellular systems |
| Q35329761 | Inhibition of Salmonella enterica biofilm formation using small-molecule adenosine mimetics |
| Q31078360 | Integration and mining of malaria molecular, functional and pharmacological data: how far are we from a chemogenomic knowledge space? |
| Q36168379 | Kinase selectivity profiling by inhibitor affinity chromatography |
| Q30417855 | Mass spectrometry approaches to monitor protein-drug interactions |
| Q27667472 | Mechanism-Based Inhibition of Quinone Reductase 2 (NQO2): Selectivity for NQO2 over NQO1 and Structural Basis for Flavoprotein Inhibition |
| Q37033564 | Mefloquine use, psychosis, and violence: a retinoid toxicity hypothesis |
| Q42081847 | Modeling the transition state structure to probe a reaction mechanism on the oxidation of quinoline by quinoline 2-oxidoreductase |
| Q24294878 | Molecular characterization, expression analysis, and role of ALDH3B1 in the cellular protection against oxidative stress |
| Q24644134 | Multiple and additive functions of ALDH3A1 and ALDH1A1: cataract phenotype and ocular oxidative damage in Aldh3a1(-/-)/Aldh1a1(-/-) knock-out mice |
| Q41948906 | NQO2 is a reactive oxygen species generating off-target for acetaminophen. |
| Q44765114 | Novel magnetic supports for small molecule affinity capture of proteins for use in proteomics |
| Q44919797 | On the iTRAQ of kinase inhibitors |
| Q33356363 | PUMA: a puzzle piece in chloroquine's antimelanoma activity |
| Q46569263 | Photophysical Characterization and in Vitro Phototoxicity Evaluation of 5,10,15,20-Tetra(quinolin-2-yl)porphyrin as a Potential Sensitizer for Photodynamic Therapy. |
| Q57181421 | Proteome-Wide Structural Biology: An Emerging Field for the Structural Analysis of Proteins on the Proteomic Scale |
| Q40064331 | Proteomic approaches in understanding action mechanisms of metal-based anticancer drugs |
| Q36381243 | Proteomics of the human malaria parasite Plasmodium falciparum |
| Q34005966 | Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors |
| Q38606734 | Quinone reductase 2 as a promising target of melatonin therapeutic actions. |
| Q28536670 | Real-time imaging of the intracellular glutathione redox potential in the malaria parasite Plasmodium falciparum |
| Q35615371 | Rediscovering the sweet spot in drug discovery. |
| Q47251583 | Reduction and Scavenging of Chemically Reactive Drug Metabolites by NAD(P)H:Quinone Oxidoreductase 1 and NRH:Quinone Oxidoreductase 2 and Variability in Hepatic Concentrations. |
| Q36848141 | Resveratrol: Biological and pharmaceutical properties as anticancer molecule |
| Q41913490 | Role of Quinone Reductase 2 in the Antimalarial Properties of Indolone-Type Derivatives |
| Q35469447 | SNX2112, a synthetic heat shock protein 90 inhibitor, has potent antitumor activity against HER kinase-dependent cancers |
| Q36459174 | Schistosomiasis--a century searching for chemotherapeutic drugs. |
| Q36385090 | Screening and synthesis: high throughput technologies applied to parasitology |
| Q34555612 | Screening natural products for inhibitors of quinone reductase-2 using ultrafiltration LC-MS |
| Q38089202 | Small-molecule affinity chromatography coupled mass spectrometry for drug target deconvolution |
| Q38314486 | Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN): could retinoids play a causative role? |
| Q38428349 | Synthesis and biological evaluation of coumarin replacements of novobiocin as Hsp90 inhibitors |
| Q48238590 | Synthesis of Highly Functionalized 4-Aminoquinolines |
| Q47251729 | Synthesis of thieno[2,3-b]quinoline and selenopheno[2,3-b]quinoline derivatives via iodocyclization reaction and a DFT mechanistic study. |
| Q36168322 | Target class strategies in mass spectrometry-based proteomics |
| Q36961595 | Target deconvolution strategies in drug discovery |
| Q38157052 | Targeting the redox metabolism of Plasmodium falciparum |
| Q41920350 | The antimalarial drugs chloroquine and primaquine inhibit pyridoxal kinase, an essential enzyme for vitamin B6 production |
| Q37730343 | The pathogenesis of malaria: a new perspective |
| Q36159136 | The role of targeted chemical proteomics in pharmacology |
| Q35974377 | Ultraviolet radiation: cellular antioxidant response and the role of ocular aldehyde dehydrogenase enzymes. |
| Q92132074 | Unraveling Plant Natural Chemical Diversity for Drug Discovery Purposes |
Search more.